By Kevin Penton ( January 5, 2016, 11:09 PM EST) -- Gibson Dunn's life sciences practice scored a last-minute injunction for Sanofi-Aventis in a complex battle over an insulin injection device and protected the company from allegations it overcharged the U.S. hundreds of millions of dollars for another drug, earning the firm a spot on Law360's Practice Groups of the Year....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.